otogelin
| GO Term | Evidence Code | PMID |
|---|---|---|
| nervous system development | ||
| L-arabinose metabolic process |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular space | ||
| apical plasma membrane | ||
| extracellular matrix |
| GO Term | Evidence Code | PMID |
|---|---|---|
| alpha-L-arabinofuranosidase activity |
| Gene Ontology |
|---|
| L-arabinose metabolic process |
| alpha-L-arabinofuranosidase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0110474 | autosomal recessive nonsyndromic deafness 18B |
| HPO ID | HPO Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000407 | Sensorineural hearing impairment |
| HP:0000750 | Delayed speech and language development |
| HP:0001756 | Vestibular hypofunction |
| HP:0003577 | Congenital onset |
| Disease ID | Disease Name |
|---|---|
| OMIM:614945 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026